Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Innovative Capitainer®SEP10 Revolutionizes Blood Plasma Sampling

Capitainer, a leading Swedish MedTech company specializing in advanced self-sampling solutions, has announced the launch of a new sampling card designed for collecting separated blood from a finger prick. Capitainer®SEP10 generates a plasma-like sample without the need for a centrifuge, providing at-home sampling capabilities to areas previously not feasible, making it ideal for testing substances that cannot be measured from a whole blood sample. Capitainer's innovative sampling card Capitainer®SEP10 is developed for collection of blood where the cells are separated from the

Capsol Technologies ASA - Q3 2024: Strengthened CCS business case for emitters drives demand growth

Capsol Technologies ASA, a provider of carbon capture technology to large emitters, today announced its results for Q3 2024.Steady demand growth · Revenues up 80% to NOK 21.6 million, compared to same period in 2023. · Mature project pipeline up ~60% to 15 million tons CO2, representing potential pre-tax profits of more than NOK 1.2 billion. · Growing traction in cement sector with award of feasibility study from cement producer in Germany and CapsolGo® campaigns with SCHWENK, a leading European cement producer.   Lower cost solution yields attractive returns for emitters

Vestas – Interim Financial Report, Third Quarter 2024

Vestas Wind Systems A/S, Aarhus, 05 November 2024Company Announcement no. 16/2024 Summary: Quarterly revenue of EUR 5.2bn with an EBIT margin before special items of 4.5 percent. Order intake of 4.4 GW and combined order backlog of EUR 63.4bn. Revenue and EBIT margin guidance maintained with adjustments to Service EBIT and total investments. Lower end of the guidance range now more likely for the Group EBIT margin. In the third quarter of 2024, Vestas generated revenue of EUR 5,177m – an increase of 18.9 percent compared to the year-earlier period. EBIT before special items amounted

EQT X, THROUGH OAK BIDCO S.À R.L., HAS SECURED AN OWNERSHIP OF 72.5% OF THE VOTES IN OEM INTERNATIONAL AKTIEBOLAG (PUBL) AND ANNOUNCES A CASH OFFER TO ALL SHAREHOLDERS

This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important information” at the end of this announcement and in

Raisio plc’s Interim Report January-September 2024

Raisio Plc’s Interim Report, November 5th, 2024 at 8.30 a.m. Finnish timeNet sales grew driven by sales volumes   FINANCIAL DEVELOPMENT IN BRIEF   JULY–SEPTEMBER 2024, CONTINUING OPERATIONS • The Group's net sales totalled EUR 59.1 (56.1) million, which signified a growth of 5.4%.• Comparable EBITDA was EUR 9.0** (9.9) million, which accounted for 15.2 (17.6) per cent of net sales.• EBITDA was EUR 8.1* (9.6*) million, which accounted for 13.7 (17.0) per cent of net sales.• Comparable EBIT was EUR 6.5** (7.4) million, accounting for 11.1 (13.1) per cent of net sales.•

Lytix Biopharma - Update from licensing partner Verrica Pharmaceuticals

Oslo, November 5th, 2024: Lytix Biopharma, a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, refers to the third quarter announcement made by its licensing partner Verrica Pharmaceuticals November 4th, 2024.   In the release, Verrica Pharmaceuticals reported financial results, provided an update on its strategies to strengthen the balance sheet and announced a new management.   Dr. Jayson Rieger is appointed as new CEO of Verrica Pharmaceuticals. Rieger is also a board member of Lytix Biopharma and will continue as part of the Board of

AMSC ASA - Ex dividend today

Lysaker, 5 November 2024 Reference is made to the Company's Q3 2024 report, regarding the Board's authorization to pay a quarterly dividend of NOK 0.60 per share to the shareholders of AMSC on record as of  6 November 2024. The shares in AMSC ASA will be traded ex dividend NOK 0.60 as from today, 5 November 2024. The dividend will be paid on or about 12 November 2024 and is classified as a return of paid in capital. *** About AMSC ASA: Established in 2005 and listed on the Euronext Oslo Stock Exchange (ticker AMSC), AMSC is a yield driven maritime investment company.  The

High-quality nanomechanical resonators with built-in piezoelectricity

Researchers at Chalmers University of Technology in Sweden and at the University of Magdeburg in Germany have developed a novel type of nanomechanical resonator that combines two important features: high mechanical quality and piezoelectricity. This development could open doors to new possibilities in quantum sensing technologies. Mechanical resonators have been used for centuries for a multitude of applications. A key aspect of these devices is their ability to vibrate at specific frequencies. A well-known example is the tuning fork. When struck, the tuning fork oscillates at

Cost reductions offseting lower volumes – New cost initiatives and record New Business Wins YTD support long-term growth and profitability

Kongsberg, November 5, 2024: Financial Highlights – Q3 2024 · Revenues MEUR 181.6 (MEUR 220.6) · EBIT MEUR 1.1 (MEUR 9.7) · Net result after tax MEUR -4.0 (MEUR 5.8) · Free cash flow MEUR -5.2 (MEUR -13.4) · 2024 full year revenue guidance of MEUR 760-790, EBIT of MEUR 18-23 and new business wins of MEUR >1,500 Kongsberg Automotive ASA (KA) has published its results for the third quarter of 2024 with revenues of MEUR 181.6, a decrease of 16.9% (at constant currencies) compared to the same period last year. The EBIT of MEUR 1.1 in the quarter reflects the lower revenue

Fazer is Finland's second most reputable company in 2024

According to the Reputation &Trust survey, monitoring the reputation of companies, Fazer is Finland’s second most reputable company in 2024. Finns have named Fazer one of Finland's most reputable companies already for twelve years.Reputation & Trust surveys the general public’s views on the reputation of companies operating in Finland. In the 2024 survey, Fazer improved its results in three of the eight dimensions of reputation, with the biggest improvements in innovations and dialogue. During the year, the company has, among others, launched the world's first chocolate tablet containing

NoHo Partners Plc’s Interim Report 1 January–30 September 2024: Sustainable and profitable growth in challenging market

NoHo Partners Plc, Stock Exchange Release, 5 November 2024 at 8:00 EET NoHo Partners Plc’s Interim Report 1 January–30 September 2024: Sustainable and profitable growth in challenging market This release is a summary of NoHo Partner’s Interim Report for 1 January–30 September 2024. The complete report is attached to this release and is also available at www.noho.fi/en. JULY-SEPTEMBER IN BRIEF •         Turnover was MEUR 106.6 (96.0) and increased by 11.0%. •         Operational EBITDA was MEUR 12.2 (10.6) and increased by 15.7%. •         EBIT was MEUR 9.9 (8.7) and

SmartCraft ASA (SMCRT) – Q3 2024: Continued high growth and strong cash flow, margins impacted by acquisitions and one-off items

5 November 2024 - SmartCraft ASA, the leading Nordic provider of mission-critical SaaS solutions to small and mid-sized companies in the construction sector, today reported its results for the third quarter of 2024, with continued solid revenue growth, strong cash flow, but margins impacted by dilutive acquisitions and one-off items. Reported revenue in the second quarter grew 32 percent year-on-year to NOK 132 million, of which 94 percent was recurring. During the third quarter, SmartCraft has started to transform the business models in the newly acquired companies to increase their

NoHo Partners Plc’s Financial Reporting in 2025

NoHo Partners Plc, Stock Exchange Release, 5 November 2024 at 7:55 EET NoHo Partners Plc’s Financial Reporting in 2025 In 2025, NoHo Partners Plc will publish financial information as follows: Financial Statements Release 2024 on Wednesday 12 February 2025 approx. at 8:00Interim Report 1 January–31 March 2025 on Tuesday 6 May 2025 approx. at 8:00Half-Year Report 1 January–30 June 2025 on Tuesday 5 August 2025 approx. at 8:00Interim Report 1 January–30 September 2025 on Tuesday 4 November 2025 approx. at 8:00 NoHo Partners observes a silent period of 30 days prior to

New analysis: uncertain if the EU’s new due diligence rules help protect Sámi herding communities in Sweden from negative impacts of mining

Critical minerals are crucial components in renewable energy technologies and key to achieving Sweden’s 2045 net-zero goal. At the same time, new mining activities on Sámi lands are set to increase adverse impacts on traditional livelihoods such as reindeer herding, fishing and hunting, leading to economic, social and cultural disruption.Many hope that the EU’s new Corporate Sustainability Due Diligence Directive (CSDDD) can help address such goal conflicts. The directive, which will enter into force from mid-2027, will require large businesses to identify, prevent, and address adverse

Strong biological performance in the Faroe Islands and successful de-risking in Scotland

The Bakkafrost Group delivered a total operational EBIT of DKK 173 million (DKK 269 million) in Q3 2024.(Figures in parenthesis refer to the same period last year unless otherwise specified) The performance in Q3 2024 per region was as follows: · Faroe Islands             Revenues of DKK 1,420 million (1,628 million)                                    Operational EBIT of DKK 310 million (542 million) · Scotland                    Revenues of DKK 317 million (232 million)                                    Operational EBIT of DKK -138 million (-263 million) Commenting

Lundin Gold Reports Additional High-Grade Drilling Intercepts at FDNS And Updates on Conversion Drilling Program

Recent drilling results confirm the continuity and growth potential of FDNS as a new high-grade system across the south of FDNVANCOUVER, BC, November 4, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased to announce additional results from its ongoing 2024 near-mine and conversion drilling programs at its 100% owned Fruta del Norte (“FDN”) gold mine in southeast Ecuador. Recent drilling results at FDN South (“FDNS”) confirm the continuity and the high-grade nature of this mineralized system across the southern

Etrion Releases Third Quarter 2024 Results

November 4, 2024, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and nine months ended September 30, 2024. Q3-24 HIGHLIGHTS · Etrion closed the third quarter of 2024 with an unrestricted cash balance of US$7.1 million and a positive working capital of US$6.5 million. · On September 30, 2024, the Group's Luxembourg subsidiary received an earn-out payment of US$1.2

Nordea Bank Abp: Repurchase of own shares on 04.11.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares04.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 04.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |137,786|11.06 |1,524,464.

David Meek is proposed as new Chair of the Board of Directors of Sobi

The Nomination Committee of Swedish Orphan Biovitrum AB (publ) (Sobi®) proposes that David Meek is elected as new Chair of the Board of Directors of Sobi. Sobi intends to convene an Extraordinary General Meeting to be held in December 2024.David Meek currently serves as a member of the Board of Directors of Cullinan Therapeutics, uniQure (Chair) and the University of Southern California School of Pharmacy and Pharmaceutical Sciences. He also has previous experience from board work in listed pharmaceutical companies and US and European trade associations. David Meek has extensive experience

Communique from the EXTRAORDINARY General Meeting OF SHAREHOLDERS in Eevia Health Plc

The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. Reg. No 2825194-4 (the “Company”) was held on November 4, 2024, in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters.For immediate release Seinäjoki, Finland, November 4, 2022   Election of the Members of the Board of Directors The Annual General Meeting resolved, for the time until the end of the next Annual General Meeting, to re-elect Per Benjaminsen and Oskar Wegelius and elect Terry Virts, Dr. Diane E. Clayton, and Anders Eriksson as Members of the Board of

Announcement from the Extraordinary General Meeting of Spermosens AB (publ)

Spermosens AB ("Spermosens" or the "Company") held an Extraordinary General Meeting today, 4 November 2024. At the meeting, the shareholders approved all previously announced proposals. The decisions can be summarized as follows: The meeting resolved to reduce the share capital without cancelling shares, to cover losses, through an amendment of the Articles of Association and a decision to reduce the share capital. The new limits for the share capital are a minimum of SEK 560,000 and a maximum of SEK 2,240,000. The number of shares will be between 280,000,000 and 1,120,000,000.

ABS Showcases Commitment to Saudi Maritime Industry at Saudi Maritime & Logistics Congress

ABS demonstrated its commitment to the Saudi maritime industry during the recent Saudi Maritime & Logistics Congress at the Dhahran Expo in Dammam, Saudi Arabia. The event showcased the potential of Saudi Arabia as a burgeoning hub for the maritime sector as it undergoes transformative changes under the Vision 2030 initiative. With a heritage in Saudi Arabia dating back five decades, ABS remains a trusted partner in the region, continually expanding its presence and capabilities to support the country's goal of becoming a global maritime leader. Representing ABS at the event

There are no items matching the current filter
There are no more items matching the current filter
Back to top